Indication
Controlled Ovarian Hyperstimulation
1 clinical trial
2 products
Product
BG2109Clinical trial
A Randomized, Double-blind, Open for Active Comparator, Parallel, Multi-center Phase II Study to Explore the Efficacy, Safety and Tolerability of BG2109 Compared With Cetrorelix During COH in Female Subjects Undergoing ART ProceduresStatus: Not yet recruiting, Estimated PCD: 2024-06-01
Product
Cetrorelix